Acquisition by Janus Henderson Group Plc of 94537 shares of ARCA Biopharma at 3.4516 subject to Rule 16b-3

About 67% of ARCA Biopharma's investor base is looking to short. The analysis of current outlook of investing in ARCA Biopharma suggests that many traders are alarmed regarding ARCA Biopharma's prospects. ARCA Biopharma's investing sentiment overview a quick insight into current market opportunities from investing in ARCA Biopharma. Many technical investors use ARCA Biopharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by ARCA Biopharma 10 Percent Owner. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Acquisition of 94537 common stock at 3.4516 of ARCA Biopharma by Janus Henderson Group Plc on 11th of July 2024. This event was filed by ARCA Biopharma with SEC on 2024-07-11. Statement of changes in beneficial ownership - SEC Form 4

ARCA Biopharma Fundamental Analysis

We analyze ARCA Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ARCA Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ARCA Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Institutions

Shares Owned By Institutions Comparative Analysis

ARCA Biopharma is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

ARCA Biopharma Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ARCA Biopharma stock to make a market-neutral strategy. Peer analysis of ARCA Biopharma could also be used in its relative valuation, which is a method of valuing ARCA Biopharma by comparing valuation metrics with similar companies.

Peers

ARCA Biopharma Related Equities

TPSTTempest Therapeutics   21.13   
0%
100.0%
RNXTRenovoRx   3.20   
0%
15.0%
INDPIndaptus Therapeutics   2.16   
0%
10.0%
SPROSpero Therapeutics   1.90   
0%
8.0%
FBRXForte Biosciences   1.86   
0%
8.0%
AVTEAerovate Therapeutics   1.56   
0%
7.0%
TILInstil Bio   0.78   
0%
3.0%
RZLTRezolute   0.68   
3.0%
0%
CTMXCytomX Therapeutics   1.83   
8.0%
0%
ANTXAN2 Therapeutics   2.86   
13.0%
0%
KTTAPasithea Therapeutics   3.01   
14.0%
0%
ADAGAdagene   5.37   
25.0%
0%
ACRVAcrivon Therapeutics,   8.64   
40.0%
0%
NXTCNextCure   10.52   
49.0%
0%
QNRXQuoin Pharmaceuticals   14.89   
70.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Consideration for investing in ARCA Stock

If you are still planning to invest in ARCA Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ARCA Biopharma's history and understand the potential risks before investing.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine